May 27 2010
CompuMed, Inc. (OTCBB: CMPD) (http://www.compumed.net), a telemedicine and medical informatics company, reported its CardioGram® and OsteoGram® systems have been incorporated as core components of Visio Mobile Diagnostics' suite of telemedicine and digital x-ray-based healthcare services.
“These advanced technologies bring the highest quality medical services to an increasingly wide array of patients in a practical and affordable way. We look forward to working closely with Visio Mobile Diagnostics, one of the nation's premier innovators and providers of state-of-the-art mobile health care services.”
Visio Mobile Diagnostics is Ohio's largest provider of mobile x-ray and cardiac testing services, serving a wide array of regional and state government entities, leading corporations, healthcare organizations and professional sports teams. Visio has begun to rollout CompuMed's digital telemedicine technology to hospitals, occupational and home health clients, as well as long-term care facilities in mobile and rural markets across Ohio.
Visio's mobile services bring the diagnostic testing center directly to the patient. Services are scheduled at times that are convenient for the patient and can be provided virtually anywhere, including at home or work, or in long-term care facilities or the local physician's office.
"Our CardioGram and OsteoGram technologies represent our leading eHealth initiatives, and they are revolutionizing the capabilities of mobile health care delivery," said Maurizio Vecchione, president and CEO of CompuMed. "These advanced technologies bring the highest quality medical services to an increasingly wide array of patients in a practical and affordable way. We look forward to working closely with Visio Mobile Diagnostics, one of the nation's premier innovators and providers of state-of-the-art mobile health care services."
According to Doug Cook, CEO of Visio Mobile Diagnostics, "Our clients and staff are very impressed with the CardioGram and OsteoGram systems, which we have been able to rapidly implement in a demanding healthcare environment. We see this as a major game changer for us, helping us to solidify our position as Ohio's premier provider of mobile medical testing services."
This announcement follows CompuMed's recently initiated campaign to reach underserved markets for cardiac care, which include geriatric, pediatric and rural healthcare. CompuMed plans to reach these markets by building upon its existing network of hundreds of CardioGram sites nationwide, each accessing advanced cardiovascular diagnostic services through Compumed's telemedicine infrastructure.
CompuMed has launched a series of initiatives designed to deliver its telecardiology services via industry partners, like Visio, that already provide healthcare services to underserved markets. "We believe the changed reimbursement posture towards telemedicine allows us to offer these services to patients without creating new costs for our partners in these markets," said Vecchione.
CompuMed's long-standing status as a leader in the remote interpretation of electrocardiograms (ECGs) puts it ahead of the game in the emerging market for telemedicine, which is expected to nearly triple over the next three years, topping $1.6 billion according to Datamonitor.
AI outperforms doctors in diagnostics but falls short as a clinical assistant